MedTrace Logo

Effects of an Educational Intervention Program on Marble Factory Workers

NCT06479785 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-01-23

No results posted yet for this study

Summary

Marble cutting exposes workers to dust, increasing risk of lung diseases like asthma, COPD, silicosis, and asbestosis. Many marble cutters in rural areas lack awareness of these risks and work without proper protection. Khyber Pakhtunkhwa has over 4000 marble factories employing over a million laborers, mostly unskilled and vulnerable. Workers face health risks from heavy lifting, poor posture, and respirable dust. Ergonomic disorders are also common due to poorly designed workstations, repetitive motions, and straining postures. Musculoskeletal Symptoms (MSS) can progress into Musculoskeletal Disorders (MSDs), affecting worker well-being and productivity. Findings can inform targeted educational programs and interventions to improve respiratory health and reduce ergonomic risks in the marble industry.

Conditions

Interventions

OTHER

Educational Intervention Program for machine workers

A detailed Educational Intervention Program for marble factory workers working on Machines.

OTHER

Educational Intervention Program for manual workers

A detailed Educational Intervention Program for marble factory workers working manually.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Suman Sheraz, PhD* · Riphah International University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2024-11-30
Completion
2024-12-10

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06479785 on ClinicalTrials.gov